Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,955 total articles
UniFirst Corporation announced its fiscal Q3 2026 financial results, reporting a 3.9% increase in consolidated revenues to $634.4 million driven by organic growth in its core Uniform & Facility Service segment. However, operating income and net income declined compared to the previous year, primarily due to $20.7 million in costs related to the pro…
Atlantic International Corp., trading as ATLN on Nasdaq and recently rebranding as Circle8, announced a one-year $175 million contract extension with Rijkswaterstaat, the Dutch Ministry of Infrastructure and Water Management. This renewal reaffirms Circle8's long-standing partnership and leadership in providing comprehensive technology solutions su…
Nasdaq reported the strongest first half in U.S. exchange history with $129.3 billion raised from new listings in 2026, fueled by historic IPOs including SpaceX’s largest-ever IPO. The exchange showcased broad participation across sectors such as AI, aerospace, biotech, and energy while launching Nasdaq Texas as a dual listing venue to boost region…
Park Ha Biological Technology Co., Ltd. has submitted a full application for membership to the Personal Care Products Council (PCPC), a key regulatory and industry body in North America. This move is a strategic step to align the company with U.S. regulations and standards, facilitating its entry into Amazon's North America marketplace and future e…
TON Strategy Company has established a Rule 10b5-1 trading plan to repurchase its common stock over a two-month period starting July 1, 2026. The repurchase plan utilizes part of the company's existing $250 million stock buyback authorization. Management cites the stock trading at a discount to intrinsic value and strong belief in the TON ecosystem…
Trust Stamp announced the successful deployment of its first compliance-focused Sovereign Large Language Model (LLM) for an international telecommunications company. This on-premises AI model ensures data sovereignty, privacy, and operational independence, addressing client concerns over data security and costly reliance on hyperscale AI providers.…
SunPower Inc. successfully closed a $10 million equity-for-interest exchange related to its Convertible Notes, aiming to reduce costs and increase financial flexibility. The company believes Q2 2026 marked a low point for the U.S. residential solar industry and expects strong growth ahead with a record backlog heading into Q3. CEO T.J. Rodgers rema…
Stryker Corporation, a global leader in medical technologies, announced it will webcast its second quarter 2026 financial results on July 30, 2026. The company will issue a press release with summary financial information prior to the webcast. Stryker's products span MedSurg, Neurotechnology, and Orthopaedics, impacting over 150 million patients an…
Genius Group Limited reported strong Q2 2026 results with operational revenue doubling year-over-year to $3.2 million and shifting from a $2.3 million net loss in Q2 2025 to a $4.3 million net operating profit. The growth was fueled by all three of its business units—Genius School, Genius Academy, and Genius Resorts—as well as strategic investments…
Pacira BioSciences announced that UnitedHealthcare, the largest health insurer in the U.S., now provides separate reimbursement for EXPAREL across outpatient settings, including hospitals and ambulatory surgery centers. This policy change broadens patient access to non-opioid pain management options and aligns with broader trends among major payers…
Terra Innovatum Global N.V. filed its Q1 2026 Form 10-Q, regaining current SEC reporting status. The company reported continued investments and progress in licensing, procurement, manufacturing readiness, and commercialization planning for its SOLO™ micro modular nuclear reactor, targeting first-of-a-kind deployment within three years. Financial re…
SLR Investment Corp., a specialty finance company focused on lending to U.S. middle market companies, announced it will release its financial results for Q2 ending June 30, 2026, on August 4, 2026, followed by an earnings call on August 5. The company invests primarily in senior secured loans and asset-backed loans to leveraged middle market firms.
NewAmsterdam Pharma announced it will present clinical data at the Alzheimer's Association International Conference 2026, highlighting obicetrapib, its oral CETP inhibitor initially developed for cardiovascular disease, as a promising low-dose therapy for early Alzheimer's disease prevention. The presentations include biomarker analyses from the BR…
BridgeBio Pharma, a US-based biopharmaceutical company (Nasdaq: BBIO), announced a $1 billion preferred equity investment led by Sixth Street and HealthCare Royalty (a business of KKR). The financing, which includes a convertible preferred stock with an initial 7% dividend and a conversion price at a significant premium to market price, aims to bol…
NorthStrive Biosciences, a subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB), announced positive Phase III results from their AI-driven drug discovery collaboration with Yuva Biosciences. Four AI-selected small-molecule compounds demonstrated significant induction of the mitochondrial protein ANT1 in human skeletal muscle cells, supporting further co…
FortuneX Acquisition Corporation announced that its IPO units, each consisting of one ordinary share and one redeemable warrant, can now be separated and traded independently on the Nasdaq starting July 1, 2026. Unseparated units will continue trading under FXACU, while separated shares and warrants will trade under FXAC and FXACW respectively.
FTI Consulting announced a significant increase and extension of its senior unsecured revolving credit facility from $900 million to $1.5 billion, with maturity extended to June 2031. This follows the company's recent upgrade to investment grade by S&P Global and includes improved pricing and less restrictive covenants, providing greater financial …
Streamex Corp. announced that EisnerAmper LLP completed the first independent examination confirming that the GLDY tokens are fully backed by gold reserves meeting or exceeding 100%, marking the start of ongoing monthly attestations. This third-party verification supports transparency and institutional trust in GLDY, Streamex's gold-backed, yield-b…
New Era Energy & Digital, a Nasdaq-listed company focused on developing large-scale data centers in energy-rich U.S. markets, announced a leadership transition effective July 1, 2026. Charlie Nelson has been promoted to Chairman and CEO, while Ted Warner becomes President and CFO, and José Rodriguez joins as COO bringing extensive data center and e…
Kustom Entertainment, Inc. announced record-breaking attendance of over 42,000 fans at its 30th anniversary Country Stampede festival in Kansas, surpassing projections by 10,000. Fueled by strong demand and a newly announced multi-season partnership with Gilley's Park City, the company plans to expand event capacity significantly in 2027. Multiple …
Marex Group Limited has completed its redomiciliation from England and Wales to Bermuda, effective July 1, 2026. This move follows shareholder approval and regulatory and court sanctioning. The redomiciliation aims to rationalize the company's corporate and regulatory framework, deliver cost savings, and align its governance under Bermuda's US-styl…
Hotel101 Global Holdings Corp. (NASDAQ: HBNB) announced definitive binding agreements to jointly develop a large 770-room Hotel101 in Bangkok, Thailand, in partnership with Origin Property PCL. Positioned in a prime location near Don Mueang International Airport and a BTS Skytrain station, the hotel aims to be one of Bangkok's largest by room count…
GlobalFoundries announced it will host a conference call on August 5, 2026, to review its second quarter 2026 financial results. The company is a leading semiconductor manufacturer serving multiple high-growth markets with global operations.
Biotech firm Ocugen, Inc. announces participation in multiple July 2026 conferences to showcase its modifier gene therapy platform targeting blindness diseases. Presentations will cover updates on ongoing clinical trials and research advances in retinal disease therapies, highlighting the company’s gene-agnostic approach aimed at treating complex i…
Ocular Therapeutix, a biopharmaceutical company focused on retinal diseases, announced its participation in several prominent scientific and investor conferences in July 2026. Key presentations will include Phase 3 clinical trial results for its investigational intravitreal axitinib hydrogel (AXPAXLI/OTX-TKI) targeting neovascular age-related macul…
